Does sleep medication affect next day performance in athletes
- Conditions
- SleepNeurological - Studies of the normal brain and nervous system
- Registration Number
- ACTRN12620001272987
- Lead Sponsor
- Australian Catholic University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- 18
Participants must be non-smoking males between the ages of 18-35 years, be free of any medical conditions that are likely to impact sleep, not be taking medication that is likely to disrupt sleep, and must meet the criteria of a well-trained athlete (i.e., train 3-7 times per week for at least 60 min for the last 3-5 years).
Participants will be excluded if they have unusual sleep/wake patterns, work irregular
hours, experienced a previous adverse reaction to any sleep medication, suffer from lung disease, liver damage, glaucoma, epilepsy, depression, psychosis, schizophrenia, low blood pressure, any blood disorder, or myasthenia gravis, or if they have a history of drug or alcohol dependence. Participants who currently use sleep medication will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overnight sleep:<br>Sleep will be recorded using polysomnography equipment (Grael; Compumedics, Melbourne, VIC, Australia) with a standard montage of electrodes. Electrodes will be applied in the 60 min prior to lights out and include three electroencephalograms (C4-M1, F4-M1, O2-M1), two electrooculograms (left/right outer canthus), and a submental electromyogram. All sleep records will be blinded and manually scored in 30-s epochs by the same technician according to established criteria. [Measured overnight, throughout the night measured immediately after consuming the intervention or placebo]
- Secondary Outcome Measures
Name Time Method